Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD

NCT: NCT06820970 · RECRUITING

NCT IDNCT06820970
StatusRECRUITING
Start Date2025-08-01
Completion2029-12-30

Brief Summary

The main objective of this study is to demonstrate whether the combination of chronic remote ischemic conditioning and mindfulness therapy can reduce cardiovascular adverse events in patients with incomplete revascularization of coronary artery disease.

Frequently Asked Questions

What is CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD?

CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD is a clinical trial registered under NCT06820970. Current status: RECRUITING.

What is the status of NCT06820970?

The current status of NCT06820970 (CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD) is: RECRUITING.

When did CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD start?

CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD started on 2025-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑